Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Antiviral Therapy|October 29, 2013
Delayed emergence of HIV-1 variants resistant to 4'-ethynyl-2-fluoro-2'-deoxyadenosine: comparative sequential passage study with lamivudine, tenofovir, emtricitabine and BMS-986001Kenji Maeda, Darshan V Desai, Manabu Aoki, et al.
Therapeutic Drug Monitoring|September 22, 2023
Dose Individualization of Cefepime for Febrile Neutropenia in Patients With Lymphoma or Multiple Myeloma: Implications for Therapeutic Drug MonitoringKazutaka Oda, Ayami Yamaguchi, Naoya Matsumoto, et al.
Scientific Reports|November 11, 2024
Diverse antifungal potency of terbinafine as a therapeutic agent against Exophiala dermatitidis in vitroTomofumi Nakamura, Tatsuya Yoshinouchi, Mayu Okumura, et al.
Antimicrobial Agents and Chemotherapy|April 2, 2008
Potent synergistic anti-human immunodeficiency virus (HIV) effects using combinations of the CCR5 inhibitor aplaviroc with other anti-HIV drugsHirotomo Nakata, Seth M Steinberg, Yasuhiro Koh, et al.
Journal of Virology|February 1, 2005
Potent anti-R5 human immunodeficiency virus type 1 effects of a CCR5 antagonist, AK602/ONO4128/GW873140, in a novel human peripheral blood mononuclear cell nonobese diabetic-SCID, interleukin-2 receptor gamma-chain-knocked-out AIDS mouse modelHirotomo Nakata, Kenji Maeda, Toshikazu Miyakawa, et al.
Antiviral Therapy|June 3, 2010
Effects of CC chemokine receptor 5 (CCR5) inhibitors on the dynamics of CCR5 and CC-chemokine-CCR5 interactionsHirotomo Nakata, Michael Kruhlak, Wakako Kamata, et al.
Antimicrobial Agents and Chemotherapy|October 29, 2008
GRL-02031, a novel nonpeptidic protease inhibitor (PI) containing a stereochemically defined fused cyclopentanyltetrahydrofuran potent against multi-PI-resistant human immunodeficiency virus type 1 in vitroYasuhiro Koh, Debananda Das, Sofiya Leschenko, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|May 31, 2025
Impact of the COVID-19 pandemic on the regional epidemiology of methicillin-resistant Staphylococcus aureus in the Kumamoto regionKeiichi Yamamoto, Hideyuki Hayashi, Kanako Mizuta, et al.
Antimicrobial Agents and Chemotherapy|June 24, 2009
Potent activity of a nucleoside reverse transcriptase inhibitor, 4'-ethynyl-2-fluoro-2'-deoxyadenosine, against human immunodeficiency virus type 1 infection in a model using human peripheral blood mononuclear cell-transplanted NOD/SCID Janus kinase 3 knockout miceShinichiro Hattori, Kazuhiko Ide, Hirotomo Nakata, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 20, 2021
Human retroviral antisense mRNAs are retained in the nuclei of infected cells for viral persistenceGuangyong Ma, Jun-Ichirou Yasunaga, Kazuya Shimura, et al.
Pageof 4